Astex Announces New Drug Discovery Collaboration With Boehringer Ingelheim
31. August 2005 02:05 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., Aug. 31, 2005 (PRIMEZONE) --Astex:
- Astex and Boehringer Ingelheim form a further strategic alliance
-- The alliance will focus on discovery, development and
...
AstraZeneca and Astex Announce New Anti-Cancer Drug Discovery Alliance
27. Juli 2005 02:08 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., July 27, 2005 (PRIMEZONE) -- Astex Therapeutics:
-- AstraZeneca and Astex form their third strategic alliance
-- Alliance focussed on discovery, development and
...
Astex Technology Changes Name to Astex Therapeutics
11. Juli 2005 02:35 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., July 11, 2005 (PRIMEZONE) -- Astex Therapeutics:
Full press release attached below: http://hugin.info/132636/R/1001855/153544.pdf
CONTACT: Astex Therapeutics Limited
...
Astex Announces IND Approval for Novel Cancer Drug AT7519
27. Juni 2005 02:38 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., June 27, 2005 (PRIMEZONE) -- Astex Technology Ltd.:
-- Astex announces FDA approval of IND application for novel
cancer drug
-- AT7519 went from first synthesis to IND...
Astex Announces Clinical Trial Authorization for Novel Cancer Drug AT7519 and Plans for Two Further New Drug Filings in the Next Nine Months
23. Mai 2005 03:35 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., May 23, 2005 (PRIMEZONE) -- Astex:
-- Astex announces first CTA for novel cancer drug
-- AT7519 went from first synthesis to CTA approval in just 14 months
-- less than...
Neil Gallagher, MD PhD, Joins Astex as Director of Clinical Development
07. März 2005 02:36 ET
|
Astex Therapeutics
CAMBRIDGE, United Kingdom, March 7, 2005 (PRIMEZONE) -- Astex Technology Ltd:
-- Astex Technology, the fragment-based drug discovery and development
company, today announced the appointment...
Astex Achieves Drug Discovery Milestone with Boehringer Ingelheim
14. Februar 2005 02:35 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., Feb. 14, 2005 (PRIMEZONE) -- * Astex, the fragment-based drug discovery and development company, today announced that it has successfully achieved the first milestone in its drug...
Dr. Peter Ringrose joins Astex Board
01. Februar 2005 03:34 ET
|
Astex Therapeutics
CAMBRIDGE, United Kingdom, Feb. 01, 2005 (PRIMEZONE) -- * Astex Technology, the fragment-based drug discovery and development company, today announced the appointment of Dr Peter Ringrose to its...
Astex Technology, the Fragment-Based Drug Discovery and Development Company, Today Announced Issuance of Patent GB2395718 Covering the Use of the Crystal Structure of Human Cytochrome P450 3A4, the Most Important Drug Metabolising Enzyme in Man
24. Januar 2005 03:09 ET
|
Astex Therapeutics
CAMBRIDGE, United Kingdom, Jan. 24, 2005 (PRIMEZONE) -- Astex Technology:
Full press release attached below: http://hugin.info/132636/R/976983/143988.pdf
CONTACT: Astex Technology
...
Astex Chosen by the World Economic Forum as a Technology Pioneer for 2005
06. Dezember 2004 02:34 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., Dec. 6, 2004 (PRIMEZONE) -- Astex, the fragment-based drug discovery and development company, has been selected as a Technology Pioneer for the World Economic Forum today. The...